Biotest Aktiengesellschaft (BIO3) — Strategic Asset Allocation Index
Biotest Aktiengesellschaft (BIO3) has a Strategic Asset Allocation Index of 148.8% as of June 2023. Strategic assets (PP&E of €555.70 Million plus long-term investments of €-) total €555.70 Million, measured against net assets of €373.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Biotest Aktiengesellschaft's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Biotest Aktiengesellschaft Strategic Asset Allocation Index (2013–2021)
This chart shows how Biotest Aktiengesellschaft's Strategic Asset Allocation Index has evolved across 9 annual periods from 2013 to 2021. As of June 2023, the index stands at 148.8%, representing strategic assets of €555.70 Million against net assets of €373.50 Million EUR. For live market cap and overall valuation, see how much is Biotest Aktiengesellschaft worth.
Annual Strategic Asset Allocation Index for Biotest Aktiengesellschaft (2013–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Biotest Aktiengesellschaft from 2013 to 2021, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Biotest Aktiengesellschaft (BIO3) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 125.3% | €476.70 Million | €476.70 Million | €- | €380.40 Million | ▲ +54.8 pp |
| 2020 | 70.5% | €311.30 Million | €311.30 Million | €- | €441.60 Million | ▲ +3.3 pp |
| 2019 | 67.2% | €320.30 Million | €320.30 Million | €- | €476.90 Million | ▲ +4.7 pp |
| 2018 | 62.4% | €309.10 Million | €307.20 Million | €1.90 Million | €495.20 Million | ▼ -24.1 pp |
| 2017 | 86.5% | €301.00 Million | €298.70 Million | €2.30 Million | €347.80 Million | ▲ +30.9 pp |
| 2016 | 55.7% | €200.80 Million | €196.50 Million | €4.30 Million | €360.70 Million | ▲ +0.8 pp |
| 2015 | 54.8% | €226.10 Million | €222.60 Million | €3.50 Million | €412.30 Million | ▲ +2.5 pp |
| 2014 | 52.4% | €251.40 Million | €249.90 Million | €1.50 Million | €480.20 Million | ▲ +0.5 pp |
| 2013 | 51.9% | €238.90 Million | €237.10 Million | €1.80 Million | €460.70 Million | — |